Moody’s upgrades Hackensack University Medical Center’s rating to ‘A2’

Moody’s Investors Service has upgraded the rating on Hackensack (N.J.) University Medical Center to “A2” from “A3,” affecting $442 million of outstanding debt.

Advertisement

The rating upgrade reflects Hackensack’s improved financial performance and debt service coverage, as well as its growth in absolute and relative liquidity measures.

The outlook is positive, reflecting Moody’s Investors Service’s expectation that Hackensack will continue to improve its operating performance.

More articles on healthcare finance:
Colo. may have to repay federal government $38M in Medicaid bonuses
Fitch assigns ‘AA-‘ ratings to Providence St. Joseph Health’s bonds
HealthTrust taps iMedx for outsourced coding services

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.